These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1645471)

  • 1. Clarification of vasotec and teprotide dosages.
    Koppel DM
    Postgrad Med; 1991 Jun; 89(8):39. PubMed ID: 1645471
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neonatal hypertension with enalaprilat.
    Wells TG; Bunchman TE; Kearns GL
    J Pediatr; 1990 Oct; 117(4):664-7. PubMed ID: 2170612
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the efficacy, safety and tolerability of intravenous enalaprilat in the treatment of grade III essential hypertension in Indian patients.
    Misra M; Chembale J; Kankane A
    Indian Heart J; 2004; 56(1):67-9. PubMed ID: 15129797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises.
    Hirschl MM; Binder M; Bur A; Herkner H; Brunner M; Müllner M; Sterz F; Laggner AN
    Arch Intern Med; 1995 Nov; 155(20):2217-23. PubMed ID: 7487244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary actions of intravenously administered enalaprilat in trauma patients.
    Boldt J; Menges T; Wollbrück M; Hammermann H; Hempelmann G
    Crit Care Med; 1994 Jun; 22(6):960-4. PubMed ID: 8205828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 8. Enalapril maleate and teprotide.
    Greenberg B
    Postgrad Med; 1991 Oct; 90(5):38. PubMed ID: 1924015
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failure.
    Acampora GA; Melendez JA; Keefe DL; Turnbull AD; Bedford RF
    Anesth Analg; 1989 Dec; 69(6):833-9. PubMed ID: 2556061
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy.
    Sluysmans T; Styns-Cailteux M; Tremouroux-Wattiez M; de Lame PA; Lintermans J; Rubay J; Vliers A
    Am J Cardiol; 1992 Oct; 70(9):959-62. PubMed ID: 1326889
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
    Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
    Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 13. Enalaprilat induced acute parotitis.
    Chauhan V; Negi RC; Sharma A; Gupta S; Mokta J; Verma B; Thakur S
    J Assoc Physicians India; 2008 Feb; 56():128-9. PubMed ID: 18472517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged hypotension by enalaprilat in a case of renal artery stenosis.
    Mirenda J; Edwards C
    Anesth Analg; 1992 Dec; 75(6):1017-20. PubMed ID: 1332550
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat.
    Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D
    Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalaprilat, an intravenous angiotensin-converting enzyme inhibitor, in hypertensive crises.
    DiPette DJ; Ferraro JC; Evans RR; Martin M
    Clin Pharmacol Ther; 1985 Aug; 38(2):199-204. PubMed ID: 2990798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema.
    Annane D; Bellissant E; Pussard E; Asmar R; Lacombe F; Lanata E; Madonna O; Safar M; Giudicelli JF; Gajdos P
    Circulation; 1996 Sep; 94(6):1316-24. PubMed ID: 8822986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
    Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
    Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.
    Vandenburg MJ; Sharman VL; Marsh FP; Rucinska EJ
    Br Med J; 1978 Sep; 2(6141):866. PubMed ID: 709099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.